Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC]

Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC] was reported 1781 times

Drugs of the Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CANCER CELLS URINE PRESENT 3 0.5000
1 HIGH INTENSITY FOCUSED ULTRASOUND 1 0.3333
2 BLADDER GRANULOMA 4 0.3333
3 BCG RELATED CYSTITIS 6 0.3000
4 BLADDER CANCER RECURRENT 187 0.1876
5 RADICAL CYSTECTOMY 6 0.1714
6 MANUFACTURING STABILITY TESTING ISSUE 1 0.1667
7 CELL MARKER 1 0.1667
8 DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION 72 0.1542
9 CYSTITIS EROSIVE 1 0.1429
10 KOEPPE NODULES 1 0.1250
11 BACILLUS CALMETTE-GUERIN INFECTION 5 0.1111
12 GENITAL ABSCESS MALE 1 0.1111
13 BLADDER DYSPLASIA 2 0.1111
14 EPIDIDYMITIS TUBERCULOUS 4 0.1081
15 SECONDARY TRANSMISSION 2 0.1000
16 EXPOSURE TO BODY FLUID 3 0.0938
17 PROSTATITIS TUBERCULOUS 1 0.0909
18 EXTRAVASATION OF URINE 2 0.0833
19 BOVINE TUBERCULOSIS 30 0.0783
20 MALE GENITAL TRACT TUBERCULOSIS 1 0.0769
21 MECONIUM INCREASED 1 0.0714
22 CONTRACTED BLADDER 11 0.0683
23 METASTASES TO URINARY TRACT 1 0.0625
24 CITROBACTER BACTERAEMIA 2 0.0588
25 TRANSITIONAL CELL CARCINOMA RECURRENT 3 0.0517
26 CHEMICAL CYSTITIS 2 0.0513
27 BIOPSY STOMACH ABNORMAL 1 0.0500
28 BLADDER TRANSITIONAL CELL CARCINOMA RECURRENT 5 0.0490
29 TRANSURETHRAL BLADDER RESECTION 4 0.0488
30 NEOBLADDER SURGERY 1 0.0455
31 MONOCYTE PERCENTAGE ABNORMAL 1 0.0455
32 PROSTATIC ATROPHY 1 0.0385
33 MENINGITIS NEONATAL 2 0.0364
34 BLADDER NEOPLASM SURGERY 5 0.0360
35 BLADDER CATHETER REMOVAL 1 0.0357
36 MYCOTIC ANEURYSM 3 0.0357
37 CONJUNCTIVAL GRANULOMA 1 0.0345
38 AORTIC PSEUDOANEURYSM 2 0.0339
39 INFECTIVE ANEURYSM 16 0.0323
40 BONE MARROW GRANULOMA 2 0.0323
41 TRANSITIONAL CELL CANCER OF THE RENAL PELVIS AND URETER 3 0.0319
42 BONE TUBERCULOSIS 12 0.0313
43 REITER'S SYNDROME 3 0.0300
44 PARAPHARYNGEAL SPACE INFECTION 1 0.0294
45 EXPOSURE TO HOUSEHOLD CHEMICALS 1 0.0294
46 BASOPHIL PERCENTAGE DECREASED 1 0.0270
47 BLADDER ULCER 1 0.0244
48 INSTILLATION SITE BURN 1 0.0233
49 ATYPICAL MYCOBACTERIAL LYMPHADENITIS 1 0.0233
50 ANTIDEPRESSANT THERAPY 1 0.0227
51 CYSTOSCOPY 3 0.0187
52 ARTERIOVENOUS GRAFT SITE INFECTION 1 0.0179
53 URINARY CYSTECTOMY 2 0.0169
54 VACCINATION FAILURE 28 0.0168
55 INFECTIVE AORTITIS 1 0.0167
56 BALANITIS 2 0.0164
57 BLADDER INJURY 5 0.0157
58 PARANEOPLASTIC NEUROLOGICAL SYNDROME 2 0.0156
59 BLADDER NECROSIS 1 0.0156
60 AORTIC BYPASS 1 0.0154
61 MYCOBACTERIUM TEST POSITIVE 3 0.0146
62 PROSTATIC ABSCESS 4 0.0145
63 INTERCOSTAL RETRACTION 1 0.0141
64 EXPOSURE VIA INHALATION 3 0.0139
65 FEEDING PROBLEM IN NEWBORN 1 0.0132
66 MEDICAL DEVICE SITE JOINT INFECTION 2 0.0128
67 BLADDER TRABECULATION 1 0.0123
68 IATROGENIC INFECTION 1 0.0122
69 BLADDER CANCER STAGE 0, WITH CANCER IN SITU 1 0.0120
70 CYSTITIS NONINFECTIVE 16 0.0119
71 EXPOSURE VIA EYE CONTACT 5 0.0119
72 BREATH SOUNDS DECREASED 1 0.0114
73 MYCOBACTERIAL INFECTION 19 0.0110
74 CUTANEOUS TUBERCULOSIS 2 0.0110
75 MIXED INCONTINENCE 1 0.0110
76 OSTEOMYELITIS BACTERIAL 3 0.0109
77 BLADDER IRRITATION 7 0.0109
78 IMMUNE RECONSTITUTION SYNDROME 14 0.0108
79 PENILE ABSCESS 1 0.0108
80 CLINICALLY ISOLATED SYNDROME 1 0.0105
81 AORTO-OESOPHAGEAL FISTULA 1 0.0104
82 AORTIC EMBOLUS 1 0.0104
83 PRODUCT AVAILABILITY ISSUE 236 0.0104
84 ATYPICAL MYCOBACTERIUM TEST POSITIVE 1 0.0103
85 MANUFACTURING PRODUCTION ISSUE 1 0.0096
86 PRODUCT SUPPLY ISSUE 67 0.0094
87 URETHRAL CANCER 2 0.0093
88 NEPHROSTOMY 3 0.0091
89 PENILE NECROSIS 1 0.0090
90 JOINT TUBERCULOSIS 1 0.0089
91 CYSTITIS BACTERIAL 3 0.0089
92 BLADDER SPASM 16 0.0085
93 CORONARY ARTERY ANEURYSM 2 0.0085
94 METASTATIC CARCINOMA OF THE BLADDER 3 0.0085
95 NECROTIC LYMPHADENOPATHY 1 0.0083
96 BLADDER MASS 4 0.0081
97 TRANSURETHRAL PROSTATECTOMY 4 0.0080
98 PROSTATITIS 24 0.0079
99 URINARY BLADDER RUPTURE 2 0.0079
100 DIARRHOEA NEONATAL 1 0.0079
101 MEDIASTINAL ABSCESS 1 0.0077
102 BRIEF RESOLVED UNEXPLAINED EVENT 1 0.0076
103 BLADDER NECK OBSTRUCTION 1 0.0073
104 AUTOMATIC BLADDER 1 0.0072
105 OCCUPATIONAL EXPOSURE TO PRODUCT 46 0.0071
106 MENINGOENCEPHALITIS BACTERIAL 1 0.0068
107 ANTICOAGULATION DRUG LEVEL ABNORMAL 1 0.0067
108 ORCHITIS 7 0.0065
109 MECONIUM STAIN 1 0.0065
110 NEOPLASM PROSTATE 2 0.0064
111 DISSEMINATED TUBERCULOSIS 16 0.0062
112 BLOOD URINE 6 0.0062
113 ACID FAST BACILLI INFECTION 1 0.0062
114 TRANSITIONAL CELL CARCINOMA 8 0.0062
115 NEONATAL ASPIRATION 2 0.0061
116 HLA MARKER STUDY POSITIVE 1 0.0061
117 GRAFT INFECTION 2 0.0059
118 PNEUMONITIS ASPIRATION 2 0.0058
119 BLOOD LACTIC ACID DECREASED 1 0.0058
120 BASOPHIL PERCENTAGE INCREASED 1 0.0057
121 GRANULOMATOUS LIVER DISEASE 4 0.0057
122 EXPULSION OF MEDICATION 3 0.0057
123 PRODUCT RECONSTITUTION QUALITY ISSUE 5 0.0056
124 LOWER URINARY TRACT SYMPTOMS 2 0.0055
125 MONOCYTE PERCENTAGE DECREASED 1 0.0054
126 OESOPHAGEAL NEOPLASM 1 0.0054
127 GRANULOMATOUS LYMPHADENITIS 1 0.0053
128 INJECTION SITE ULCER 5 0.0053
129 HAEMOFILTRATION 1 0.0053
130 GRANULOMA 18 0.0052
131 BLADDER PERFORATION 2 0.0052
132 URETHRAL PAIN 3 0.0051
133 POOR SUCKING REFLEX 2 0.0050
134 URETERIC CANCER 2 0.0050
135 URETHRAL OBSTRUCTION 2 0.0049
136 GLOMERULONEPHRITIS ACUTE 1 0.0049
137 GENITAL LESION 2 0.0047
138 CATHETER SITE INJURY 1 0.0047
139 PRODUCT NAME CONFUSION 5 0.0046
140 INFERTILITY MALE 2 0.0044
141 URETHRAL STENOSIS 3 0.0044
142 AORTITIS 3 0.0044
143 URINARY TRACT DISCOMFORT 2 0.0043
144 NECROTISING SOFT TISSUE INFECTION 1 0.0043
145 HAEMORRHAGE URINARY TRACT 11 0.0043
146 FOETAL HEART RATE DECELERATION 1 0.0043
147 INJECTION SITE GRANULOMA 1 0.0042
148 PAROPHTHALMIA 1 0.0042
149 MYCOBACTERIUM ABSCESSUS INFECTION 3 0.0042
150 EXPOSURE VIA PARTNER 2 0.0040
151 SUPRAPUBIC PAIN 2 0.0039
152 MONONUCLEOSIS SYNDROME 1 0.0039
153 PACHYMENINGITIS 1 0.0038
154 BACTEROIDES INFECTION 1 0.0038
155 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 9 0.0038
156 KLEBSIELLA URINARY TRACT INFECTION 1 0.0038
157 METASTASES TO KIDNEY 2 0.0036
158 CULTURE URINE POSITIVE 5 0.0036
159 GENITOURINARY TRACT INFECTION 1 0.0035
160 PENILE BURNING SENSATION 1 0.0035
161 CREUTZFELDT-JAKOB DISEASE 1 0.0035
162 BLADDER OPERATION 4 0.0034
163 EXTRAPULMONARY TUBERCULOSIS 1 0.0034
164 NEPHRECTOMY 5 0.0034
165 HEPATORENAL FAILURE 2 0.0033
166 BLADDER TAMPONADE 1 0.0033
167 INCARCERATED HERNIA 1 0.0032
168 HEPATIC ISCHAEMIA 1 0.0032
169 FOETAL HEART RATE DECREASED 2 0.0032
170 METASTASES TO PELVIS 2 0.0032
171 BLADDER CATHETERISATION 3 0.0031
172 EXTRAOCULAR MUSCLE DISORDER 1 0.0031
173 PENILE ULCERATION 1 0.0031
174 HIV TEST POSITIVE 2 0.0030
175 BACTERIAL PYELONEPHRITIS 1 0.0030
176 BRAIN MASS 1 0.0030
177 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 2 0.0029
178 ANION GAP DECREASED 1 0.0029
179 POLYMERASE CHAIN REACTION POSITIVE 1 0.0029
180 PANCREATIC INSUFFICIENCY 1 0.0028
181 GLOMERULONEPHRITIS PROLIFERATIVE 1 0.0028
182 TUBERCULIN TEST POSITIVE 7 0.0028
183 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 1 0.0028
184 PRODUCT DOSE OMISSION 177 0.0027
185 HYDROURETER 1 0.0026
186 OVARIAN ENLARGEMENT 1 0.0026
187 AORTIC RUPTURE 1 0.0026
188 MITRAL VALVE REPLACEMENT 1 0.0025
189 PRODUCT SUBSTITUTION 1 0.0025
190 LYMPHADENITIS 6 0.0025
191 LYMPHOCYTE PERCENTAGE INCREASED 1 0.0025
192 GRANULOCYTE COUNT INCREASED 1 0.0025
193 CONJUNCTIVITIS INFECTIVE 1 0.0025
194 VACCINATION COMPLICATION 2 0.0024
195 ANAEMIA HAEMOLYTIC AUTOIMMUNE 2 0.0024
196 BLADDER DISCOMFORT 3 0.0024
197 URINARY BLADDER HAEMORRHAGE 5 0.0024
198 BLADDER NEOPLASM 4 0.0023
199 NITRITE URINE PRESENT 1 0.0023
200 POST-TRAUMATIC PAIN 1 0.0022
201 RECURRENT CANCER 9 0.0022
202 BLADDER PAIN 7 0.0022
203 BIOPSY 2 0.0022
204 EATING DISORDER SYMPTOM 1 0.0022
205 BACTERIAL SEPSIS 7 0.0021
206 INTERVERTEBRAL DISCITIS 4 0.0021
207 BLADDER TRANSITIONAL CELL CARCINOMA 3 0.0021
208 CANCER SURGERY 2 0.0021
209 NO ADVERSE EVENT 378 0.0021
210 AUTOIMMUNE PANCREATITIS 1 0.0020
211 BLADDER OBSTRUCTION 1 0.0019
212 BLADDER DYSFUNCTION 2 0.0019
213 ALVEOLITIS ALLERGIC 2 0.0019
214 STRESS URINARY INCONTINENCE 2 0.0019
215 LYMPHOCYTOSIS 4 0.0019
216 EPHELIDES 1 0.0019
217 GENITAL DISCOMFORT 1 0.0018
218 PRODUCT CLOSURE ISSUE 1 0.0018
219 MENINGITIS TUBERCULOUS 1 0.0018
220 LIFE SUPPORT 1 0.0018
221 CATHETER SITE INFLAMMATION 1 0.0018
222 PROSTATECTOMY 1 0.0017
223 LACRIMAL DISORDER 1 0.0017
224 EPIDIDYMITIS 2 0.0017
225 AORTIC ANEURYSM 13 0.0017
226 MICTURITION URGENCY 19 0.0017
227 ALLERGY TO METALS 1 0.0016
228 BLOOD IMMUNOGLOBULIN M INCREASED 1 0.0016
229 PENILE SWELLING 2 0.0016
230 MONOCYTOSIS 1 0.0016
231 PSOAS ABSCESS 1 0.0016
232 ARTHRITIS REACTIVE 1 0.0016
233 THERAPY NON-RESPONDER 72 0.0016
234 NEPHRITIS INTERSTITIAL 2 0.0016
235 TESTICULAR SWELLING 2 0.0016
236 APGAR SCORE LOW 2 0.0016
237 CHORIORETINITIS 1 0.0016
238 PERITONEAL DISORDER 1 0.0015
239 CATARACT NUCLEAR 1 0.0015
240 PARANEOPLASTIC SYNDROME 1 0.0015
241 EMERGENCY CARE EXAMINATION 1 0.0015
242 CYTOKINE STORM 1 0.0015
243 EPISCLERITIS 1 0.0014
244 CLEAR CELL RENAL CELL CARCINOMA 1 0.0014
245 POSITRON EMISSION TOMOGRAM ABNORMAL 1 0.0014
246 THERAPEUTIC PROCEDURE 2 0.0014
247 ATRIAL TACHYCARDIA 3 0.0014
248 MONOCYTE PERCENTAGE INCREASED 1 0.0014
249 BLADDER DISORDER 14 0.0014
250 CRYOGLOBULINAEMIA 1 0.0014
251 WRONG DRUG ADMINISTERED 12 0.0013
252 CORNEAL DEPOSITS 1 0.0013
253 MONOCLONAL IMMUNOGLOBULIN PRESENT 1 0.0013
254 PREMATURE SEPARATION OF PLACENTA 2 0.0013
255 INCORRECT PRODUCT STORAGE 17 0.0013
256 CRITICAL ILLNESS 1 0.0013
257 EXTRADURAL ABSCESS 1 0.0013
258 PRODUCT INEFFECTIVE 1 0.0013
259 EXPOSURE VIA BODY FLUID 1 0.0013
260 URINARY TRACT OBSTRUCTION 3 0.0013
261 ELECTROMECHANICAL DISSOCIATION 1 0.0013
262 PELVIC MASS 1 0.0012
263 IIIRD NERVE PARALYSIS 1 0.0012
264 HYPOGLYCAEMIA NEONATAL 2 0.0012
265 PENILE HAEMORRHAGE 1 0.0012
266 PSEUDOMONAS TEST POSITIVE 1 0.0012
267 OXYGEN THERAPY 2 0.0012
268 IGA NEPHROPATHY 2 0.0012
269 INJECTION SITE ABSCESS 3 0.0012
270 OESOPHAGEAL RUPTURE 1 0.0012
271 DYSURIA 44 0.0012
272 NEOPLASM RECURRENCE 4 0.0012
273 CAROTID ARTERY THROMBOSIS 1 0.0012
274 PSEUDOMONAL BACTERAEMIA 1 0.0012
275 HAEMATURIA 40 0.0012
276 CYSTITIS 37 0.0012
277 TREATMENT DELAYED 2 0.0012
278 PULMONARY CAVITATION 1 0.0011
279 HILAR LYMPHADENOPATHY 1 0.0011
280 ANAEMIA OF CHRONIC DISEASE 1 0.0011
281 CERUMEN IMPACTION 1 0.0011
282 COLOUR BLINDNESS 1 0.0011
283 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0011
284 ADENOCARCINOMA GASTRIC 1 0.0011
285 ADVERSE FOOD REACTION 1 0.0011
286 BONE GRAFT 1 0.0011
287 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 36 0.0011
288 OVARIAN DISORDER 1 0.0011
289 WHITE BLOOD CELLS URINE POSITIVE 2 0.0011
290 PELVIC DISCOMFORT 1 0.0011
291 EXPOSURE VIA DIRECT CONTACT 1 0.0011
292 RADIOTHERAPY 2 0.0010
293 HYPERTONIC BLADDER 3 0.0010
294 IDIOSYNCRATIC DRUG REACTION 1 0.0010
295 BLOOD CULTURE POSITIVE 3 0.0010
296 EJACULATION FAILURE 2 0.0010
297 GASTRECTOMY 1 0.0010
298 BRAIN HYPOXIA 1 0.0010
299 PENILE PAIN 3 0.0010
300 CONJUNCTIVAL OEDEMA 1 0.0010
301 LIGHT CHAIN ANALYSIS INCREASED 1 0.0010
302 BENIGN PROSTATIC HYPERPLASIA 5 0.0010
303 HYPOPERFUSION 1 0.0010
304 STAPHYLOCOCCUS TEST POSITIVE 2 0.0009
305 FOETAL DISTRESS SYNDROME 2 0.0009
306 BLADDER DILATATION 1 0.0009
307 EXPIRED PRODUCT ADMINISTERED 30 0.0009
308 BACTERIAL TEST POSITIVE 2 0.0009
309 BENIGN NEOPLASM 1 0.0009
310 URINE ABNORMALITY 4 0.0009
311 HYPERSENSITIVITY PNEUMONITIS 1 0.0009
312 BLOOD FIBRINOGEN DECREASED 1 0.0009
313 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
314 PELVIC ABSCESS 1 0.0009
315 DIFFUSE ALVEOLAR DAMAGE 1 0.0009
316 MICTURITION DISORDER 3 0.0009
317 MUCOSAL HAEMORRHAGE 1 0.0009
318 PAROTITIS 1 0.0009
319 GLOMERULONEPHRITIS MEMBRANOUS 1 0.0009
320 INSTILLATION SITE IRRITATION 1 0.0008
321 BILE DUCT CANCER 1 0.0008
322 URINE FLOW DECREASED 2 0.0008
323 ESCHERICHIA TEST POSITIVE 1 0.0008
324 CEREBRAL ARTERY EMBOLISM 1 0.0008
325 CATHETER SITE HAEMORRHAGE 2 0.0008
326 AORTIC VALVE REPLACEMENT 1 0.0008
327 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
328 URINARY TRACT INFECTION BACTERIAL 2 0.0008
329 CAROTID ARTERY DISEASE 1 0.0008
330 HEPATOSPLENOMEGALY 2 0.0008
331 CATHETER SITE PAIN 2 0.0008
332 LUNG OPACITY 2 0.0008
333 INCONTINENCE 8 0.0008
334 OESOPHAGEAL HAEMORRHAGE 1 0.0008
335 LIP EXFOLIATION 1 0.0008
336 MYCOBACTERIUM AVIUM COMPLEX INFECTION 2 0.0007
337 BODY MASS INDEX INCREASED 1 0.0007
338 BLOOD URINE PRESENT 14 0.0007
339 ALVEOLITIS 1 0.0007
340 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
341 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
342 NONINFECTIVE GINGIVITIS 1 0.0007
343 PANCREATIC ENZYMES INCREASED 1 0.0007
344 GENITAL PAIN 1 0.0007
345 AXILLARY PAIN 1 0.0007
346 ADHESION 1 0.0007
347 NOCTURIA 8 0.0007
348 PROSTATIC SPECIFIC ANTIGEN INCREASED 9 0.0007
349 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 1 0.0007
350 HYPERTROPHIC CARDIOMYOPATHY 1 0.0006
351 IDIOPATHIC THROMBOCYTOPENIC PURPURA 1 0.0006
352 INCORRECT DOSE ADMINISTERED BY PRODUCT 1 0.0006
353 LOOSE TOOTH 2 0.0006
354 INCOHERENT 4 0.0006
355 TREATMENT FAILURE 51 0.0006
356 LEUKOCYTOCLASTIC VASCULITIS 1 0.0006
357 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
358 ESCHERICHIA INFECTION 5 0.0006
359 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
360 POLLAKIURIA 25 0.0006
361 METASTASES TO LYMPH NODES 4 0.0006
362 DEAFNESS BILATERAL 1 0.0006
363 LOWER RESPIRATORY TRACT CONGESTION 1 0.0006
364 EXPOSURE VIA SKIN CONTACT 15 0.0006
365 PYELONEPHRITIS 5 0.0006
366 FEAR OF DISEASE 1 0.0006
367 INDURATION 1 0.0006
368 INTENTIONAL UNDERDOSE 4 0.0005
369 PRODUCT PHYSICAL CONSISTENCY ISSUE 3 0.0005
370 LOBAR PNEUMONIA 1 0.0005
371 INCORRECT ROUTE OF DRUG ADMINISTRATION 19 0.0005
372 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
373 HYPOREFLEXIA 1 0.0005
374 PROSTATOMEGALY 2 0.0005
375 URINARY INCONTINENCE 15 0.0005
376 DEVICE RELATED SEPSIS 1 0.0005
377 INJURY ASSOCIATED WITH DEVICE 10 0.0005
378 OSTEOLYSIS 1 0.0005
379 ARTHRITIS BACTERIAL 2 0.0005
380 PRODUCT PREPARATION ERROR 10 0.0005
381 ACCIDENTAL EXPOSURE 2 0.0005
382 PURULENT DISCHARGE 2 0.0005
383 EXOPHTHALMOS 1 0.0005
384 METASTATIC NEOPLASM 2 0.0005
385 POOR QUALITY DRUG ADMINISTERED 3 0.0005
386 POLYP 3 0.0005
387 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
388 ACCIDENT AT WORK 1 0.0005
389 PARESIS 1 0.0004
390 PSEUDOMEMBRANOUS COLITIS 1 0.0004
391 ACCIDENTAL EXPOSURE TO PRODUCT 46 0.0004
392 APHTHOUS STOMATITIS 1 0.0004
393 INTERCEPTED MEDICATION ERROR 2 0.0004
394 ARTHRITIS INFECTIVE 2 0.0004
395 ESCHERICHIA BACTERAEMIA 1 0.0004
396 BLADDER CANCER 25 0.0004
397 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 1 0.0004
398 VIRAL UPPER RESPIRATORY TRACT INFECTION 2 0.0004
399 EOSINOPHIL COUNT DECREASED 1 0.0004
400 VULVOVAGINAL PAIN 2 0.0004
401 ENTEROCOCCAL INFECTION 2 0.0004
402 GUILLAIN-BARRE SYNDROME 2 0.0004
403 PRODUCT PACKAGING CONFUSION 1 0.0004
404 INCORRECT DOSAGE ADMINISTERED 2 0.0004
405 GLOMERULONEPHRITIS 1 0.0004
406 INSTILLATION SITE PAIN 1 0.0004
407 DRUG DOSE OMISSION 66 0.0004
408 LYMPHADENOPATHY 14 0.0004
409 BRAIN ABSCESS 1 0.0004
410 TOXIC ENCEPHALOPATHY 2 0.0004
411 ENDODONTIC PROCEDURE 1 0.0004
412 MEAN CELL VOLUME INCREASED 1 0.0004
413 AORTIC ARTERIOSCLEROSIS 1 0.0004
414 ABSCESS 6 0.0004
415 ASPIRATION 4 0.0004
416 PRODUCT DOSE OMISSION ISSUE 107 0.0004
417 ELECTRIC SHOCK SENSATION 1 0.0004
418 PRODUCT LEAKAGE 2 0.0004
419 EJACULATION DISORDER 1 0.0004
420 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
421 VISUAL DISTURBANCE 2 0.0003
422 LUNG CANCER METASTATIC 1 0.0003
423 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
424 BACTERAEMIA 4 0.0003
425 HEPATITIS B 2 0.0003
426 MYELOFIBROSIS 1 0.0003
427 INJECTION SITE VESICLES 2 0.0003
428 URINARY RETENTION 11 0.0003
429 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
430 NO THERAPEUTIC RESPONSE 4 0.0003
431 CHEST X-RAY ABNORMAL 1 0.0003
432 HYPERCALCAEMIA 4 0.0003
433 PRODUCT DISTRIBUTION ISSUE 3 0.0003
434 FLANK PAIN 3 0.0003
435 ABDOMINAL ADHESIONS 1 0.0003
436 IRIDOCYCLITIS 1 0.0003
437 SPUTUM DISCOLOURED 3 0.0003
438 ADVERSE EVENT 29 0.0003
439 SEPSIS 35 0.0003
440 LOSS OF THERAPEUTIC RESPONSE 1 0.0003
441 EXPOSURE TO TOXIC AGENT 1 0.0003
442 ACUTE RESPIRATORY FAILURE 6 0.0003
443 NIGHT SWEATS 10 0.0003
444 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0003
445 CHILLS 36 0.0003
446 LYMPHOCYTE COUNT INCREASED 1 0.0003
447 HEPATOMEGALY 3 0.0003
448 PRODUCT PREPARATION ISSUE 2 0.0003
449 CORONAVIRUS INFECTION 2 0.0003
450 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
451 NEPHRITIS 1 0.0003
452 PROSTATE CANCER METASTATIC 1 0.0003
453 INITIAL INSOMNIA 3 0.0003
454 ENCEPHALITIS 2 0.0003
455 BRONCHIOLITIS 1 0.0003
456 JAUNDICE CHOLESTATIC 1 0.0003
457 URINARY TRACT INFECTION 48 0.0003
458 PRODUCT CONTAMINATION 1 0.0003
459 MONOCYTE COUNT INCREASED 1 0.0003
460 LIVER TRANSPLANT 1 0.0003
461 STAPHYLOCOCCAL INFECTION 9 0.0003
462 MEDICAL DEVICE COMPLICATION 2 0.0003
463 INFLUENZA LIKE ILLNESS 22 0.0003
464 HYDRONEPHROSIS 2 0.0003
465 PRODUCT STORAGE ISSUE 1 0.0003
466 NEOPLASM 3 0.0003
467 DRUG ADMINISTRATION ERROR 8 0.0003
468 GINGIVAL DISORDER 1 0.0003
469 METASTASES TO LUNG 3 0.0003
470 NAIL DISCOLOURATION 1 0.0003
471 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 18 0.0003
472 CEREBRAL ATROPHY 1 0.0003
473 MUSCLE HAEMORRHAGE 1 0.0002
474 FRUSTRATION TOLERANCE DECREASED 2 0.0002
475 UNDERDOSE 18 0.0002
476 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
477 APPLICATION SITE EXFOLIATION 1 0.0002
478 AORTIC DISSECTION 1 0.0002
479 PYREXIA 83 0.0002
480 DERMATITIS 5 0.0002
481 HAEMODIALYSIS 2 0.0002
482 MALIGNANT NEOPLASM PROGRESSION 24 0.0002
483 LUNG NEOPLASM 1 0.0002
484 PRODUCT DISPENSING ISSUE 1 0.0002
485 ERECTILE DYSFUNCTION 6 0.0002
486 PSEUDOMONAS INFECTION 2 0.0002
487 MULTI-ORGAN FAILURE 4 0.0002
488 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
489 OCULAR ICTERUS 1 0.0002
490 ILL-DEFINED DISORDER 14 0.0002
491 DIVERTICULUM INTESTINAL 1 0.0002
492 GROIN PAIN 2 0.0002
493 LUNG INFILTRATION 2 0.0002
494 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
495 PAPILLOEDEMA 1 0.0002
496 OSTEOMYELITIS 4 0.0002
497 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
498 PATHOGEN RESISTANCE 2 0.0002
499 PNEUMONIA BACTERIAL 2 0.0002
500 DYSPAREUNIA 1 0.0002
501 UROSEPSIS 2 0.0002
502 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
503 LOCALISED OEDEMA 1 0.0002
504 MASS 3 0.0002
505 TUBULOINTERSTITIAL NEPHRITIS 4 0.0002
506 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
507 SKIN REACTION 3 0.0002
508 SINUS TACHYCARDIA 3 0.0002
509 PRODUCT PACKAGING ISSUE 2 0.0002
510 POST PROCEDURAL COMPLICATION 4 0.0002
511 AUTOIMMUNE DISORDER 2 0.0002
512 ORGANISING PNEUMONIA 1 0.0002
513 ABDOMINAL TENDERNESS 1 0.0002
514 PRODUCT QUALITY ISSUE 27 0.0002
515 PRODUCT PHYSICAL ISSUE 4 0.0002
516 KLEBSIELLA INFECTION 1 0.0002
517 THERAPY INTERRUPTED 14 0.0002
518 ENDOCARDITIS 1 0.0002
519 PRODUCT COLOUR ISSUE 1 0.0002
520 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
521 CACHEXIA 1 0.0002
522 PERITONITIS 4 0.0002
523 INCORRECT DOSE ADMINISTERED 44 0.0002
524 FAILURE TO THRIVE 1 0.0002
525 BLOOD LACTIC ACID INCREASED 1 0.0002
526 POLYARTHRITIS 1 0.0002
527 RENAL PAIN 2 0.0002
528 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 34 0.0002
529 PHARYNGOLARYNGEAL PAIN 1 0.0002
530 ANAL FISTULA 1 0.0002
531 ANAL ABSCESS 1 0.0002
532 GINGIVITIS 1 0.0002
533 PRODUCT STORAGE ERROR 16 0.0002
534 NONSPECIFIC REACTION 1 0.0002
535 INTRACRANIAL PRESSURE INCREASED 1 0.0002
536 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
537 ACUTE PULMONARY OEDEMA 1 0.0002
538 MITRAL VALVE INCOMPETENCE 2 0.0002
539 HYPERVENTILATION 1 0.0002
540 METABOLIC DISORDER 1 0.0002
541 POST PROCEDURAL HAEMORRHAGE 2 0.0002
542 PRODUCT LABEL CONFUSION 1 0.0002
543 SURGERY 10 0.0002
544 CATARACT OPERATION 1 0.0002
545 PLEURISY 1 0.0002
546 ODYNOPHAGIA 1 0.0002
547 HYPERLIPIDAEMIA 2 0.0002
548 ENDOPHTHALMITIS 1 0.0002
549 LEUKOCYTOSIS 3 0.0002
550 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
551 INGUINAL HERNIA 1 0.0002
552 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
553 OLIGURIA 1 0.0002
554 BACTERIAL INFECTION 3 0.0002
555 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
556 NASAL DRYNESS 1 0.0002
557 PHOTOPSIA 1 0.0002
558 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
559 THERAPY CESSATION 8 0.0002
560 DRUG RESISTANCE 4 0.0002
561 CARDIAC FLUTTER 1 0.0002
562 HEPATITIS ACUTE 1 0.0002
563 HERPES SIMPLEX 1 0.0002
564 ANGINA UNSTABLE 1 0.0002
565 PLATELET COUNT INCREASED 2 0.0002
566 NODULE 2 0.0002
567 DYSGRAPHIA 1 0.0002
568 IMMUNE SYSTEM DISORDER 2 0.0002
569 PRODUCT FORMULATION ISSUE 1 0.0002
570 MENINGITIS 1 0.0001
571 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
572 QUALITY OF LIFE DECREASED 2 0.0001
573 PRODUCT USE ISSUE 28 0.0001
574 PRODUCT ADMINISTRATION ERROR 3 0.0001
575 POSTOPERATIVE WOUND INFECTION 1 0.0001
576 FEEDING DISORDER 3 0.0001
577 PNEUMONITIS 4 0.0001
578 ACUTE HEPATIC FAILURE 2 0.0001
579 EYE MOVEMENT DISORDER 1 0.0001
580 NEPHROTIC SYNDROME 1 0.0001
581 DIALYSIS 2 0.0001
582 DIVERTICULUM 1 0.0001
583 LIVER FUNCTION TEST INCREASED 3 0.0001
584 LETHARGY 8 0.0001
585 ACCIDENTAL UNDERDOSE 2 0.0001
586 PANIC REACTION 1 0.0001
587 PRODUCT DISPENSING ERROR 3 0.0001
588 PRODUCT PRESCRIBING ISSUE 3 0.0001
589 LIVER FUNCTION TEST ABNORMAL 4 0.0001
590 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
591 GASTROENTERITIS 2 0.0001
592 CEREBRAL DISORDER 1 0.0001
593 LIPASE INCREASED 1 0.0001
594 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
595 PROCEDURAL COMPLICATION 1 0.0001
596 DEVICE RELATED INFECTION 2 0.0001
597 HAEMOLYSIS 1 0.0001
598 CONGENITAL ANOMALY 1 0.0001
599 TENDONITIS 2 0.0001
600 THERAPY PARTIAL RESPONDER 2 0.0001
601 MULTIPLE ALLERGIES 1 0.0001
602 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
603 PRODUCT USE COMPLAINT 2 0.0001
604 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
605 BLOOD ALBUMIN DECREASED 1 0.0001
606 BLOOD DISORDER 1 0.0001
607 SENSORY DISTURBANCE 2 0.0001
608 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
609 DRUG INTOLERANCE 12 0.0001
610 MYASTHENIA GRAVIS 1 0.0001
611 LUNG DISORDER 6 0.0001
612 POLYURIA 1 0.0001
613 ABNORMAL FAECES 1 0.0001
614 METASTASES TO BONE 2 0.0001
615 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
616 CYTOMEGALOVIRUS INFECTION 2 0.0001
617 HEMIPLEGIA 1 0.0001
618 COAGULOPATHY 2 0.0001
619 BLOOD UREA INCREASED 2 0.0001
620 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
621 HYPOPHAGIA 3 0.0001
622 HEPATITIS 3 0.0001
623 CARDIAC OPERATION 1 0.0001
624 ANURIA 1 0.0001
625 HYSTERECTOMY 1 0.0001
626 DELIRIUM 4 0.0001
627 DISCOMFORT 7 0.0001
628 SYRINGE ISSUE 2 0.0001
629 BLOOD CALCIUM INCREASED 1 0.0001
630 METASTASES TO LIVER 2 0.0001
631 THROMBOSIS 9 0.0001
632 ANAL INCONTINENCE 1 0.0001
633 PALLOR 3 0.0001
634 PELVIC PAIN 2 0.0001
635 NERVE COMPRESSION 1 0.0001
636 PROCEDURAL PAIN 3 0.0001
637 CONJUNCTIVITIS 2 0.0001
638 HAEMOPTYSIS 3 0.0001
639 HEPATIC ENCEPHALOPATHY 1 0.0001
640 HEPATIC CIRRHOSIS 2 0.0001
641 DYSARTHRIA 4 0.0001
642 EYE INFLAMMATION 1 0.0001
643 ATELECTASIS 1 0.0001
644 DIZZINESS POSTURAL 1 0.0001
645 CHOKING 2 0.0001
646 ASCITES 3 0.0001
647 ARTHRITIS 8 0.0001
648 HOSPICE CARE 1 0.0001
649 INABILITY TO AFFORD MEDICATION 1 0.0001
650 BLOOD PRESSURE ABNORMAL 2 0.0001
651 BURNING SENSATION 7 0.0001
652 HEPATIC FAILURE 3 0.0001
653 EMPHYSEMA 1 0.0001
654 PLEURAL EFFUSION 6 0.0001
655 BONE MARROW FAILURE 2 0.0001
656 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
657 NEUTROPHIL COUNT INCREASED 1 0.0001
658 RESPIRATORY FAILURE 7 0.0001
659 PETECHIAE 1 0.0001
660 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
661 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
662 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
663 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 19 0.0001
664 BODY HEIGHT DECREASED 1 0.0001
665 BLOOD CREATININE INCREASED 6 0.0001
666 DENTAL CARIES 1 0.0001
667 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
668 VIRAL INFECTION 3 0.0001
669 TRANSAMINASES INCREASED 2 0.0001
670 RASH MACULO-PAPULAR 2 0.0001
671 HEPATOTOXICITY 2 0.0001
672 PULMONARY OEDEMA 4 0.0001
673 ORAL PAIN 2 0.0001
674 CHROMATURIA 2 0.0001
675 RHEUMATOID ARTHRITIS 10 0.0001
676 INTERNAL HAEMORRHAGE 1 0.0001
677 HYPOKALAEMIA 4 0.0001
678 EYELID OEDEMA 1 0.0001
679 HYPOXIA 3 0.0001
680 COVID-19 PNEUMONIA 1 0.0001
681 OCULAR HYPERAEMIA 4 0.0001
682 MYOCLONUS 1 0.0001
683 RENAL IMPAIRMENT 7 0.0001
684 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
685 HEPATITIS C 1 0.0001
686 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
687 PRESYNCOPE 2 0.0001
688 NEURALGIA 2 0.0001
689 CARDIOMEGALY 1 0.0001
690 ABASIA 2 0.0001
691 GENERALISED OEDEMA 1 0.0001
692 EYE SWELLING 3 0.0001
693 AGEUSIA 2 0.0001
694 POISONING 1 0.0001
695 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
696 BRAIN OEDEMA 1 0.0001
697 COLITIS 3 0.0001
698 INFLAMMATION 4 0.0001
699 UNRESPONSIVE TO STIMULI 2 0.0001
700 RASH GENERALISED 2 0.0001
701 HIATUS HERNIA 1 0.0001
702 INJECTION SITE INDURATION 1 0.0001
703 DIPLOPIA 2 0.0001
704 HAEMORRHAGE 8 0.0001
705 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
706 DEPRESSED MOOD 4 0.0001
707 NEOPLASM MALIGNANT 5 0.0001
708 HAIR TEXTURE ABNORMAL 1 0.0001
709 MALIGNANT MELANOMA 1 0.0001
710 JAUNDICE 2 0.0001
711 BLOOD BILIRUBIN INCREASED 2 0.0001
712 RASH PRURITIC 4 0.0001
713 LIMB INJURY 2 0.0001
714 MOOD ALTERED 2 0.0001
715 ATRIAL FIBRILLATION 7 0.0001
716 FEELING COLD 2 0.0001
717 CARDIO-RESPIRATORY ARREST 3 0.0001
718 ROAD TRAFFIC ACCIDENT 3 0.0001
719 NECK PAIN 4 0.0001
720 DEMENTIA 2 0.0001
721 CARPAL TUNNEL SYNDROME 1 0.0001
722 BLISTER 4 0.0001
723 BLOOD TEST ABNORMAL 1 0.0001
724 DEVICE MALFUNCTION 5 0.0001
725 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
726 BLINDNESS UNILATERAL 1 0.0001
727 RENAL FAILURE ACUTE 3 0.0001
728 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
729 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
730 HYPOACUSIS 3 0.0001
731 IMPAIRED QUALITY OF LIFE 1 0.0001
732 PANCREATIC CARCINOMA 2 0.0001
733 DEVICE LEAKAGE 3 0.0001
734 MYELODYSPLASTIC SYNDROME 1 0.0001
735 HYPOKINESIA 1 0.0001
736 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
737 FLUID OVERLOAD 1 0.0001
738 DYSSTASIA 2 0.0001
739 CARDIOMYOPATHY 1 0.0001
740 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
741 IMMUNODEFICIENCY 1 0.0001
742 ADVERSE DRUG REACTION 6 0.0001
743 DRUG INEFFECTIVE 88 0.0001
744 MALAISE 29 0.0001
745 BLOOD COUNT ABNORMAL 1 0.0001
746 HIP ARTHROPLASTY 1 0.0001
747 PNEUMONIA 21 0.0001
748 MYALGIA 11 0.0001
749 DELUSION 1 0.0001
750 LUNG INFECTION 1 0.0001
751 ACUTE MYELOID LEUKAEMIA 1 0.0001
752 NERVOUS SYSTEM DISORDER 2 0.0001
753 CYANOSIS 1 0.0001
754 HEAD INJURY 2 0.0001
755 DISEASE RECURRENCE 3 0.0001
756 PRODUCTIVE COUGH 3 0.0001
757 FEELING ABNORMAL 15 0.0001
758 LACTIC ACIDOSIS 2 0.0001
759 DRUG LEVEL INCREASED 1 0.0001
760 RENAL FAILURE 8 0.0001
761 LEUKOPENIA 3 0.0001
762 FLUID RETENTION 3 0.0001
763 HEPATIC ENZYME INCREASED 4 0.0001
764 BALANCE DISORDER 5 0.0001
765 FATIGUE 45 0.0001
766 DEVICE DEFECTIVE 1 0.0001
767 LOCAL SWELLING 1 0.0001
768 PANCREATITIS 3 0.0001
769 COLD SWEAT 1 0.0001
770 HEAD DISCOMFORT 1 0.0001
771 TACHYCARDIA 5 0.0001
772 GOUT 1 0.0001
773 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
774 INFECTION 8 0.0001
775 C-REACTIVE PROTEIN INCREASED 2 0.0001
776 BLOOD GLUCOSE ABNORMAL 1 0.0001
777 PANCYTOPENIA 3 0.0001
778 HYPONATRAEMIA 3 0.0001
779 PHOTOPHOBIA 1 0.0001
780 BLOOD SODIUM DECREASED 1 0.0001
781 ARTHRALGIA 22 0.0001
782 FEELING JITTERY 1 0.0001
783 ACUTE KIDNEY INJURY 8 0.0001
784 EYE IRRITATION 3 0.0001
785 DRUG PRESCRIBING ERROR 1 0.0001
786 GLAUCOMA 1 0.0001
787 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
788 HERNIA 1 0.0001
789 DECREASED APPETITE 12 0.0001
790 ORAL HERPES 1 0.0001
791 KIDNEY INFECTION 1 0.0001
792 DISABILITY 1 0.0001
793 HEART RATE INCREASED 5 0.0001
794 HAEMATOCRIT DECREASED 1 0.0001
795 COMPLICATION OF DEVICE INSERTION 1 0.0001
796 PRESCRIBED UNDERDOSE 1 0.0001
797 JOINT SWELLING 6 0.0000
798 EXTRA DOSE ADMINISTERED 2 0.0000
799 DRY MOUTH 4 0.0000
800 VISUAL IMPAIRMENT 6 0.0000
801 TREMOR 8 0.0000
802 ASTHENIA 18 0.0000
803 KNEE ARTHROPLASTY 1 0.0000
804 MOUTH ULCERATION 1 0.0000
805 HALLUCINATION, VISUAL 1 0.0000
806 GAIT DISTURBANCE 9 0.0000
807 LOSS OF CONSCIOUSNESS 6 0.0000
808 RECTAL HAEMORRHAGE 2 0.0000
809 COUGH 13 0.0000
810 SEPTIC SHOCK 2 0.0000
811 MELAENA 1 0.0000
812 BLOOD PRESSURE DECREASED 3 0.0000
813 INSOMNIA 12 0.0000
814 DEHYDRATION 6 0.0000
815 HYPOTENSION 9 0.0000
816 GLOSSODYNIA 1 0.0000
817 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
818 HEART RATE IRREGULAR 1 0.0000
819 NEPHROLITHIASIS 2 0.0000
820 MUSCLE TWITCHING 1 0.0000
821 WEIGHT DECREASED 12 0.0000
822 COGNITIVE DISORDER 2 0.0000
823 SLEEP DISORDER 3 0.0000
824 DYSPHAGIA 4 0.0000
825 RENAL CANCER 2 0.0000
826 PRODUCT PRESCRIBING ERROR 1 0.0000
827 ANAEMIA 8 0.0000
828 RASH ERYTHEMATOUS 2 0.0000
829 DIABETIC KETOACIDOSIS 1 0.0000
830 AGITATION 3 0.0000
831 LIVER INJURY 1 0.0000
832 NAUSEA 32 0.0000
833 VOMITING 19 0.0000
834 DYSGEUSIA 3 0.0000
835 MYOCARDIAL INFARCTION 7 0.0000
836 PNEUMONIA ASPIRATION 1 0.0000
837 CELLULITIS 2 0.0000
838 ABDOMINAL PAIN LOWER 1 0.0000
839 PRODUCT COMPLAINT 1 0.0000
840 HAEMATEMESIS 1 0.0000
841 HAEMOGLOBIN DECREASED 4 0.0000
842 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
843 DEAFNESS 1 0.0000
844 SPEECH DISORDER 2 0.0000
845 JOINT STIFFNESS 1 0.0000
846 BRADYCARDIA 2 0.0000
847 EAR INFECTION 1 0.0000
848 PLATELET COUNT DECREASED 4 0.0000
849 FEAR 1 0.0000
850 CONFUSIONAL STATE 6 0.0000
851 FREQUENT BOWEL MOVEMENTS 1 0.0000
852 OEDEMA 2 0.0000
853 VISION BLURRED 5 0.0000
854 DIVERTICULITIS 1 0.0000
855 MENTAL STATUS CHANGES 1 0.0000
856 ARTHROPATHY 2 0.0000
857 INTENTIONAL DOSE OMISSION 1 0.0000
858 CONVULSION 2 0.0000
859 HYPERSOMNIA 1 0.0000
860 NEEDLE ISSUE 1 0.0000
861 DYSPHONIA 2 0.0000
862 PAIN 21 0.0000
863 ACUTE MYOCARDIAL INFARCTION 1 0.0000
864 LABORATORY TEST ABNORMAL 1 0.0000
865 WHEEZING 2 0.0000
866 DYSPNOEA 19 0.0000
867 DEVICE ISSUE 3 0.0000
868 BLOOD POTASSIUM DECREASED 1 0.0000
869 APHASIA 1 0.0000
870 LACRIMATION INCREASED 1 0.0000
871 HYPERTENSION 7 0.0000
872 STOMATITIS 2 0.0000
873 VERTIGO 2 0.0000
874 BLOOD PRESSURE INCREASED 5 0.0000
875 PERIPHERAL SWELLING 5 0.0000
876 PRODUCT USE IN UNAPPROVED INDICATION 8 0.0000
877 INJECTION SITE ERYTHEMA 4 0.0000
878 SWELLING 3 0.0000
879 ANXIETY 9 0.0000
880 METABOLIC ACIDOSIS 1 0.0000
881 MOVEMENT DISORDER 1 0.0000
882 HIP FRACTURE 1 0.0000
883 HYPERHIDROSIS 4 0.0000
884 DIARRHOEA 20 0.0000
885 DEEP VEIN THROMBOSIS 2 0.0000
886 DEPRESSION 7 0.0000
887 EYE DISORDER 1 0.0000
888 LIP SWELLING 1 0.0000
889 GAIT INABILITY 1 0.0000
890 SOMNOLENCE 6 0.0000
891 EYE PRURITUS 1 0.0000
892 ANGER 1 0.0000
893 CEREBROVASCULAR ACCIDENT 5 0.0000
894 NEUTROPENIA 4 0.0000
895 ILLNESS 3 0.0000
896 NEOPLASM PROGRESSION 1 0.0000
897 COVID-19 5 0.0000
898 HEART RATE DECREASED 1 0.0000
899 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
900 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
901 CRYING 1 0.0000
902 HYPERGLYCAEMIA 1 0.0000
903 PANIC ATTACK 1 0.0000
904 OFF LABEL USE 24 0.0000
905 BRONCHITIS 2 0.0000
906 THROMBOCYTOPENIA 3 0.0000
907 HYPOAESTHESIA 4 0.0000
908 DEATH 23 0.0000
909 RASH 11 0.0000
910 CARDIAC FAILURE 2 0.0000
911 CARDIAC FAILURE CONGESTIVE 2 0.0000
912 PROSTATE CANCER 2 0.0000
913 BLINDNESS 1 0.0000
914 NEUTROPHIL COUNT DECREASED 1 0.0000
915 OSTEOPOROSIS 1 0.0000
916 ABDOMINAL PAIN UPPER 5 0.0000
917 ABDOMINAL DISCOMFORT 4 0.0000
918 TOXICITY TO VARIOUS AGENTS 4 0.0000
919 PRURITUS 9 0.0000
920 DEVICE DISLOCATION 1 0.0000
921 MENTAL DISORDER 1 0.0000
922 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
923 LIVER DISORDER 1 0.0000
924 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
925 DIZZINESS 11 0.0000
926 MUSCLE SPASMS 4 0.0000
927 HYPERSENSITIVITY 4 0.0000
928 BLOOD CHOLESTEROL INCREASED 1 0.0000
929 CARDIAC DISORDER 2 0.0000
930 PULMONARY EMBOLISM 2 0.0000
931 NEUROPATHY PERIPHERAL 2 0.0000
932 COMA 1 0.0000
933 BLOOD GLUCOSE DECREASED 1 0.0000
934 INTERSTITIAL LUNG DISEASE 1 0.0000
935 HYPOGLYCAEMIA 1 0.0000
936 PAIN IN EXTREMITY 6 0.0000
937 DYSPEPSIA 2 0.0000
938 SYNCOPE 2 0.0000
939 CONDITION AGGRAVATED 6 0.0000
940 CHEST DISCOMFORT 2 0.0000
941 ERYTHEMA 4 0.0000
942 ABDOMINAL DISTENSION 2 0.0000
943 NERVOUSNESS 1 0.0000
944 ECZEMA 1 0.0000
945 PARAESTHESIA 3 0.0000
946 DISTURBANCE IN ATTENTION 1 0.0000
947 CONSTIPATION 4 0.0000
948 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
949 HAEMATOCHEZIA 1 0.0000
950 FALL 6 0.0000
951 MEDICATION ERROR 1 0.0000
952 INFLUENZA 2 0.0000
953 EYE PAIN 1 0.0000
954 MUSCULAR WEAKNESS 2 0.0000
955 SEIZURE 2 0.0000
956 ABDOMINAL PAIN 4 0.0000
957 BONE PAIN 1 0.0000
958 CATARACT 1 0.0000
959 IRRITABILITY 1 0.0000
960 EMOTIONAL DISTRESS 2 0.0000
961 HEADACHE 10 0.0000
962 BLOOD GLUCOSE INCREASED 3 0.0000
963 AMNESIA 1 0.0000
964 DEVICE DIFFICULT TO USE 1 0.0000
965 INFUSION RELATED REACTION 1 0.0000
966 FEBRILE NEUTROPENIA 1 0.0000
967 DRY SKIN 2 0.0000
968 INJURY 1 0.0000
969 HALLUCINATION 1 0.0000
970 HOT FLUSH 1 0.0000
971 DIABETES MELLITUS 1 0.0000
972 INJECTION SITE SWELLING 1 0.0000
973 INJECTION SITE PAIN 4 0.0000
974 HOSPITALISATION 2 0.0000
975 BACK PAIN 3 0.0000
976 CARDIAC ARREST 1 0.0000
977 GASTROINTESTINAL DISORDER 1 0.0000
978 CHEST PAIN 2 0.0000
979 CONTUSION 1 0.0000
980 WEIGHT INCREASED 2 0.0000
981 PALPITATIONS 1 0.0000
982 DRUG INTERACTION 1 0.0000
983 NASOPHARYNGITIS 1 0.0000
984 OVERDOSE 1 0.0000